Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 25.72%
March 31, 2026 25.74%
December 31, 2025 25.79%
September 30, 2025 25.42%
June 30, 2025 25.68%
March 31, 2025 23.15%
December 31, 2024 25.87%
September 30, 2024 25.13%
June 30, 2024 25.27%
March 31, 2024 25.17%
December 31, 2023 25.54%
September 30, 2023 25.18%
June 30, 2023 24.83%
March 31, 2023 25.91%
December 31, 2022 25.22%
September 30, 2022 24.42%
June 30, 2022 24.04%
March 31, 2022 24.11%
December 31, 2021 24.42%
September 30, 2021 24.05%
June 30, 2021 23.91%
March 31, 2021 24.91%
December 31, 2020 25.29%
September 30, 2020 24.87%
June 30, 2020 24.90%
Date Value
March 31, 2020 25.08%
December 31, 2019 25.30%
September 30, 2019 24.61%
June 30, 2019 25.16%
March 31, 2019 25.45%
December 31, 2018 25.04%
September 30, 2018 24.84%
June 30, 2018 24.78%
March 31, 2018 25.63%
December 31, 2017 24.94%
September 30, 2017 24.73%
June 30, 2017 24.64%
March 31, 2017 25.52%
December 31, 2016 24.66%
September 30, 2016 24.48%
June 30, 2016 24.33%
March 31, 2016 25.16%
December 31, 2015 24.45%
September 30, 2015 24.76%
June 30, 2015 24.18%
March 31, 2015 25.09%
December 31, 2014 24.35%
September 30, 2014 23.43%
June 30, 2014 24.21%
March 31, 2014 23.64%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
TSURUHA Holdings, Inc. 30.11%
Sugi Holdings Co., Ltd. 30.84%
COSMOS Pharmaceutical Corp. 20.66%
MatsukiyoCocokara & Co. 35.11%
Ain Holdings, Inc. 12.85%